- The trend backdrop is active with a 75-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
6949
TAI
Week ended 07 Aug 2026
Weekly Investor Report
Pell Bio-Med Technology Co., Ltd. · Healthcare · Biotechnology
Latest close
943.0 TWD
18.5%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 34.2% above the Trend Line and sits at 80.0% of its 52-week range. The latest completed week returned 18.5%, after a 1.9% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
66
out of 100
Latest Close
943.0 TWD
7 Aug 2026
1W Return
18.5%
latest completed week
4W Return
1.9%
short-term follow-through
12W Return
37.3%
quarterly tape
Trend Breadth
100.0%
52 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
- No major top-level risk cluster is currently dominant.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
18.5%
Latest completed week; four-week move 1.9%.
Indicator stack
100/61
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 34.2% above the Trend Line and sits at 80.0% of its 52-week range. The latest completed week returned 18.5%, after a 1.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7712-week average 0.76
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.77Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.9% over four weeks, 37.3% over 12 weeks, and 344.8% over one year. The current trend has remained active for 75 consecutive weeks.
Performance by holding period
Active trend streak75 weeks
Active weeks in one year52
Trend breadth100.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.70Latest activity-pressure read.
Pressure change-19.6%Four-week change in activity pressure.
Leadership29.26Latest relative-leadership reading.
RS change-9.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.8%Distance below the 52-week high.
13-week volatility11.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+27.1%Week of 19 Jun.
Worst week-19.8%Week of 31 Jul.
Latest week+18.5%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains4
Flat weeks0
Modest losses8
Sharp losses5
Recent vol11.3%13-week weekly-return volatility.
Base vol13.1%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew11.4% / -5.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank13 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank3 / 19
Group average-6.3%
Trend breadth31.6%
Trend31.6%active weekly trend signals
MD47.4%positive activity pressure
RS10.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape66/100
Trend, activity pressure, participation, and risk combine to a 66/100 tape read.
Indicator analysis80/100Latest 12-week confirmation: trend 12/12, activity pressure 8/12, relative leadership 12/12.
Activity pressure 0.77; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 943.0 TWD | 18.5% | 702.7 TWD | 304.6 TWD | 0.70 | 29.26 | 1.0M | On |
| 31 Jul 2026 | 796.0 TWD | -19.8% | 681.5 TWD | 299.5 TWD | 0.81 | 13.53 | 937.1K | On |
| 24 Jul 2026 | 992.0 TWD | -3.7% | 667.0 TWD | 295.4 TWD | 1.07 | 41.63 | 1.0M | On |
| 17 Jul 2026 | 1,030 TWD | 11.4% | 645.9 TWD | 289.7 TWD | 1.00 | 53.38 | 2.6M | On |
| 10 Jul 2026 | 925.0 TWD | 1.0% | 624.4 TWD | 283.6 TWD | 0.87 | 32.36 | 1.1M | On |
| 3 Jul 2026 | 916.0 TWD | 6.3% | 605.7 TWD | 278.3 TWD | 0.67 | 29.24 | 958.3K | On |
| 26 Jun 2026 | 862.0 TWD | -5.4% | 587.9 TWD | 272.9 TWD | 0.28 | 29.86 | 997.3K | On |
| 19 Jun 2026 | 911.0 TWD | 27.1% | 571.3 TWD | 267.9 TWD | -0.01 | 33.95 | 1.8M | On |
| 12 Jun 2026 | 717.0 TWD | 9.0% | 553.6 TWD | 262.4 TWD | -0.43 | 12.87 | 1.2M | On |
| 5 Jun 2026 | 658.0 TWD | 2.0% | 542.0 TWD | 258.5 TWD | -0.46 | 2.86 | 587.1K | On |
| 29 May 2026 | 645.0 TWD | -3.6% | 532.3 TWD | 255.0 TWD | -0.09 | 2.73 | 990.2K | On |
| 22 May 2026 | 669.0 TWD | -2.6% | 522.7 TWD | 251.6 TWD | 0.23 | 14.10 | 429.3K | On |
| 15 May 2026 | 687.0 TWD | -0.4% | 512.3 TWD | 247.9 TWD | 0.63 | 21.97 | 829.5K | On |
| 8 May 2026 | 690.0 TWD | -10.5% | 502.4 TWD | 244.0 TWD | 0.94 | 23.08 | 2.4M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.